BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
See today's BioWorld
Home
» Other news to note for Jan. 5, 2022
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for Jan. 5, 2022
Jan. 5, 2022
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Actinium, Alloy, Ares, Aveo, Biorchestra, Biohaven, Biontech, Champions, Covis, Cue, Cyclenium, Dotbio, Elicera, Epicentrx, Eversana, F-star, Genentech, Immunicum, Insilico, Intellia, Intravacc, Junshi, Kyverna, Lixte, LG Chem, Mannkind, Mdimune, Merck KGaA, Mindset, McQuade, Nanotic, Nikang, Novartis, Owp, PCI, Peptilogics, Pfizer, Prism, Roche, SK, Spectrum, Suono, Thirona, Twist, Vuja, Zynerba.
BioWorld
Briefs
Other news to note
Coronavirus